Homeβ€ΊSearchβ€ΊTherapeutic Advances in Psychopharmacology

Therapeutic Advances in Psychopharmacology

SAGE Publications Inc. Β· United Kingdom Β· Est. 1960

ISSN2045-1261
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
10
weeks to publish Β· journal-reported
Fast Β· vs ~15 wk median
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
1.321
H-Indexi
60
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.317
Total Worksi
621
Total Citationsi
15,590
2yr Mean Citednessi
1.96
Open Impact Factor alternative

Aims & Scope

Subject areas: Pharmacology & Pharmacy; Psychiatry; Pharmacology (medical); Psychiatry and Mental Health.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1960
FrequencyBimonthly
StatusActive (last: 2026)
Total Publications621
Publisher OrgSAGE Publishing
OA Since2018
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~10 weeks
Acceptance Rateβ€”
OA LicenseCC BY, CC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

9/12 Β· 75%
βœ…
Do you know the journal / publisher?
SAGE Publications Inc.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2045-1261
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
29
1k
2019
56
2.3k
2020
49
1.1k
2021
45
681
2022
35
713
2023
35
191
2024
38
50
2025
39
10
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Pharmacology (medical)Q1
Psychiatry and Mental HealthQ1

Subject Classification

Web of Science Categories

Pharmacology & PharmacyPsychiatry

Scopus Categories

Pharmacology (medical)Psychiatry and Mental Health

Research Topics (OpenAlex)

Schizophrenia research and treatmentTreatment of Major DepressionBipolar Disorder and TreatmentTryptophan and brain disordersElectroconvulsive Therapy StudiesHealthcare Decision-Making and RestraintsNeurotransmitter Receptor Influence on BehaviorPsychedelics and Drug StudiesMental Health and PsychiatryAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Frequently asked questions about Therapeutic Advances in Psychopharmacology

Is Therapeutic Advances in Psychopharmacology a predatory journal?

PubScope has no integrity flags on record for Therapeutic Advances in Psychopharmacology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Therapeutic Advances in Psychopharmacology?

Therapeutic Advances in Psychopharmacology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.96.

Is Therapeutic Advances in Psychopharmacology indexed in Scopus and Web of Science?

Therapeutic Advances in Psychopharmacology is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Therapeutic Advances in Psychopharmacology?

Subject areas: Pharmacology & Pharmacy; Psychiatry; Pharmacology (medical); Psychiatry and Mental Health.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref